ADMET modeling approaches in drug discovery

Area of Science:

• Drug discovery and development
• Computational chemistry
• Pharmacokinetics

Background:

• In silico prediction of ADMET properties is vital in pharmaceutical R&D.
• Small molecules constituted 64% of FDA-approved therapies in 2018.
• Early estimation of pharmacokinetic properties guides drug discovery phases.

Purpose of the Study:

• To highlight the importance of in silico ADMET prediction in pharmaceutical R&D.
• To discuss the evolution of chemoinformatics in drug discovery.
• To emphasize the role of molecular modeling in identifying ADMET data patterns.

Main Methods:

• Utilizing chemoinformatics and molecular modeling strategies.
• Applying advanced machine learning techniques.
• Analyzing ADMET data to derive knowledge.

Main Results:

• In silico ADMET prediction is a key component of pharmaceutical R&D.
• Chemoinformatics has progressed from chemometrics to machine learning.
• Molecular modeling aids in understanding complex R&D challenges.

Conclusions:

• The integration of advanced computational methods is essential for efficient drug discovery.
• Machine learning in chemoinformatics significantly improves ADMET prediction accuracy.
• In silico approaches streamline the identification and optimization of drug candidates.